Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
CASSY Better Than ASQ for Predicting Suicide Attempts in Teens With Psychiatric Symptoms
02/24/2023
Jolynn Tumolo
A comparison of the Ask Suicide-Screening Questions (ASQ) and the Computerized Adaptive Screen for Suicidal Youth (CASSY) instruments found both tools showed strong predictive validity in predicting suicide attempts in adolescents.
A comparison of the Ask Suicide-Screening Questions (ASQ) and the Computerized Adaptive Screen for Suicidal Youth (CASSY) instruments found both tools showed strong predictive validity in predicting suicide attempts in adolescents.
A comparison of the Ask...
02/24/2023
Psych Congress Network
News
Anesthetic Products Recalled
02/23/2023
Jolynn Tumolo
Two types of anesthetics are under a Class II recall due to discolored epinephrine.
Two types of anesthetics are under a Class II recall due to discolored epinephrine.
Two types of anesthetics are...
02/23/2023
Pharmacy Learning Network
News
Beta-Blocker Recalled
02/23/2023
Jolynn Tumolo
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for a beta-blocker that failed to meet dissolution specifications.
A Class II recall is active for...
02/23/2023
Pharmacy Learning Network
News
Surgical Scrub Recalled
02/23/2023
Jolynn Tumolo
A Class II recall has been issued for multiple lots of surgical antiseptic.
A Class II recall has been issued for multiple lots of surgical antiseptic.
A Class II recall has been...
02/23/2023
Pharmacy Learning Network
News
Comparative Effectiveness of Natalizumab vs Ocrelizumab for Relapsing-Remitting MS
02/22/2023
Jolynn Tumolo
Investigators evaluated disease activity, relapse occurrence, and treatment discontinuations to compare ocrelizumab and natalizumab's effectiveness in patients with multiple sclerosis.
Investigators evaluated disease activity, relapse occurrence, and treatment discontinuations to compare ocrelizumab and natalizumab's effectiveness in patients with multiple sclerosis.
Investigators evaluated disease...
02/22/2023
First Report Managed Care
News
Disease Modifying Therapy Most Beneficial Early in MS
02/22/2023
Jolynn Tumolo
Researchers recommended disease-modifying therapies be initiated early across all age groups of patients with multiple sclerosis.
Researchers recommended disease-modifying therapies be initiated early across all age groups of patients with multiple sclerosis.
Researchers recommended...
02/22/2023
First Report Managed Care
News
Wearable Devices Expected to Screen for Parkinson Disease
02/22/2023
Jolynn Tumolo
“Clinicians who are not usually engaged in tremor diagnosis could find these devices especially useful to enhance their diagnostic accuracy," researchers said.
“Clinicians who are not usually engaged in tremor diagnosis could find these devices especially useful to enhance their diagnostic accuracy," researchers said.
“Clinicians who are not usually...
02/22/2023
Annals of Long-Term Care
News
Meta-Analysis Supports COVID-19 Vaccines for Adults of All Ages
02/22/2023
Jolynn Tumolo
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that COVID-19 vaccines can create immunity against SARS-CoV-2 infection in adults of all ages and may require extra attention for older individuals.
A new meta-analysis reveals that...
02/22/2023
First Report Managed Care
News
Pandemic Telemedicine Provided Access to Multispecialty Care for Patients With MS
02/22/2023
Jolynn Tumolo
"Because people with MS are often separated from specialty care by distance or disability, telemedicine can help alleviate that burden by removing obstacles to accessing care," researchers wrote.
"Because people with MS are often separated from specialty care by distance or disability, telemedicine can help alleviate that burden by removing obstacles to accessing care," researchers wrote.
"Because people with MS are...
02/22/2023
Veterans Health Today
News
Impact of Dimethyl Fumarate for Primary Progressive MS Unclear After Open-Label Extension
02/22/2023
Jolynn Tumolo
A study comparing dimethyl fumarate to placebo for patients with primary progressive multiple sclerosis yielded mixed results, prompting investigators to recommend more research.
A study comparing dimethyl fumarate to placebo for patients with primary progressive multiple sclerosis yielded mixed results, prompting investigators to recommend more research.
A study comparing dimethyl...
02/22/2023
First Report Managed Care

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use